Macquarie Group’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-64,997
Closed -$4.62M 2092
2022
Q3
$4.62M Buy
64,997
+63,602
+4,559% +$5.44M 0.01% 1008
2022
Q2
$99K Hold
1,395
﹤0.01% 1877
2022
Q1
$111 Hold
1,395
﹤0.01% 1924
2021
Q4
$127K Hold
1,395
﹤0.01% 1863
2021
Q3
$179K Buy
1,395
+917
+192% +$128K ﹤0.01% 1823
2021
Q2
$73K Sell
478
-382
-44% -$50.3K ﹤0.01% 2067
2021
Q1
$91K Sell
860
-240
-22% -$24K ﹤0.01% 1944
2020
Q4
$87K Hold
1,100
﹤0.01% 1901
2020
Q3
$62K Hold
1,100
﹤0.01% 1906
2020
Q2
$68K Buy
+1,100
New +$44.9K ﹤0.01% 1857
2019
Q4
Sell
-1,354
Closed -$35K 1956
2019
Q3
$35K Hold
1,354
﹤0.01% 1833
2019
Q2
$40K Hold
1,354
﹤0.01% 1746
2019
Q1
$46K Buy
1,354
+942
+229% +$33.3K ﹤0.01% 1584
2018
Q4
$13K Sell
412
-1,700
-80% -$66.2K ﹤0.01% 1881
2018
Q3
$101K Sell
2,112
-25,570
-92% -$1.05M ﹤0.01% 1593
2018
Q2
$858K Buy
27,682
+13,000
+89% +$304K ﹤0.01% 1225
2018
Q1
$217K Sell
14,682
-2,948
-17% -$46K ﹤0.01% 1675
2017
Q4
$273K Buy
17,630
+10,230
+138% +$152K ﹤0.01% 1646
2017
Q3
$92K Buy
+7,400
New +$82.5K ﹤0.01% 1930

Other funds holding STAA

Macquarie Group's STAA Position: Q4 2022 in Review

Macquarie Group sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 64,997 shares — an estimated $4.62M sold.

Macquarie Group first reported a position in STAA in Q3 2017 and held it in 19 quarters. The position peaked at $4.62M in Q3 2022. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

  • Macquarie Group reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 64,997 STAAR Surgical shares in Q4 2022, an estimated $4.62M.
  • Macquarie Group first reported a position in STAAR Surgical in Q3 2017 and held it in 19 quarters.
  • Macquarie Group's STAAR Surgical position peaked at $4.62M in Q3 2022.
  • 275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.